Oral Erosions – Friday Pop Quiz 9-13
This patient also has extensive oral erosions. He tells you his only new medication is dicloxacillin, which he is taking for impetigo. How many days prior to development of the pictured eruption did this patient most likely begin taking dicloxacillin?
A. Hours-2 days
B. 7-21 days
C. 21-56 days
D. 60-90 days
E. >180 days
To find out the correct answer and read the explanation …
This patient also has extensive oral erosions. He tells you his only new medication is dicloxacillin, which he is taking for impetigo. How many days prior to development of the pictured eruption did this patient most likely begin taking dicloxacillin?
A. Hours-2 days
B. 7-21 days
C. 21-56 days
D. 60-90 days
E. >180 days
To find out the correct answer and read the explanation … 
Acne is a common skin condition that can be an important clue to an underlying endocrine disorder, such as polycystic ovarian syndrome (PCOS, Fig. 1). The first part of this 2-part series focused on the diagnosis and pathophysiology of PCOS-related acne. This article will focus on the diagnostic workup, including laboratory studies and imaging, and treatment options for patients with hormonal acne … 
Here are the highlights from the September issue of JDD!
For African American women, concerns about facial aging may be more about pigmentary concerns and shifts in underlying soft tissue volume in Understanding the Female African American Facial Aesthetic Patient.
Authors evaluate long-term safety and efficacy of ATX-101 for submental fat reduction in ATX-101 (Deoxycholic Ac … 
All of the following are true regarding the condition pictured EXCEPT:
A. Perilesional direct immunofluroescence shows granular IgA in the dermal papillae and at the dermoepidermal junction.
B. Only 20% of patients have a gluten-sensitive enteropathy.
C. It is associated with HLA-DQ2, HLA-DR3, and HLA-B8.
D. It is associated with Hashimoto's thyroiditis.
E. Cutaneous findings ar … 
During the month of September, Next Steps in Derm Ask the Expert segment gives you access to Dr. Joshua Zeichner, Director of Cosmetic and Clinical Research in Dermatology at Mount Sinai Hospital in New York City. Dr. Zeichner is one of the country's key opinion leaders in treating acne and is an expert in cosmeceuticals and skin care.
If you have questions for Dr. Zeichner on any of his area … 